Hussman Strategic Advisors’s Pfizer PFE Stock Holding History

Hussman Strategic Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Hold	42,000	–	–	0.26%	178
2025 Q4	$1.05M	Buy	+42,000	New	+$1.06M	0.25%	177
2025 Q2	–	Sell	-63,000	Closed	-$1.6M	–	275
2025 Q1	$1.6M	Buy	+63,000	New	+$1.65M	0.39%	104
2024 Q3	–	Sell	-42,000	Closed	-$1.18M	–	275
2024 Q2	$1.18M	Sell	42,000 -63,000	-60%	-$1.73M	0.32%	131
2024 Q1	$2.91M	Sell	105,000 -21,000	-17%	-$583K	0.68%	55
2023 Q4	$3.63M	Buy	126,000 +22,000	+21%	+$665K	0.82%	27
2023 Q3	$3.45M	Hold	104,000	–	–	0.66%	35
2023 Q2	$3.81M	Sell	104,000 -20,000	-16%	-$778K	0.7%	21
2023 Q1	$5.06M	Hold	124,000	–	–	0.79%	17
2022 Q4	$6.35M	Hold	124,000	–	–	1.03%	4
2022 Q3	$5.43M	Buy	124,000 +31,000	+33%	+$1.51M	0.94%	10
2022 Q2	$4.88M	Buy	93,000 +25,400	+38%	+$1.29M	0.84%	17
2022 Q1	$3.5M	Buy	67,600 +10,400	+18%	+$540K	0.68%	30
2021 Q4	$3.38M	Buy	+57,200	New	+$2.83M	0.74%	18
2014 Q2	–	Sell	-17,918	Closed	-$546K	–	210
2014 Q1	$546K	Buy	+17,918	New	+$534K	0.04%	138

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hussman Strategic Advisors's PFE Position: Q1 2026 in Review

Hussman Strategic Advisors held its Pfizer (PFE) position steady in Q1 2026 at 42,000 shares worth $1.18M. The position accounts for 0.26% of the portfolio, ranked #178.

Hussman Strategic Advisors first reported a position in PFE in Q1 2014 and has held it in 15 quarters since. The position peaked at $6.35M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Hussman Strategic Advisors held 42,000 shares of Pfizer worth $1.18M as of Q1 2026.
Hussman Strategic Advisors left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.26% of Hussman Strategic Advisors's portfolio in Q1 2026, its #178 holding.
Hussman Strategic Advisors first reported a position in Pfizer in Q1 2014 and has held it in 15 quarters since.
Hussman Strategic Advisors's Pfizer position peaked at $6.35M in Q4 2022.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.